InterStim Therapy System, Verify Evaluation System (SNS Urinary Neurostimulator 97800); (SNS Urinary Neurostimulator I
Medtronic Neuromodulation · Decision date Sep 18, 2025
What did the FDA decide?
FDA records P970004/S435 as a supplement to PMA P970004, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 18, 2025.
FDA approval order statement
approval for updates to the medium rate battery manufacturing process
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 18, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P970004/S435
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Neuromodulation
- Product code
- EZW
- Decision code
- OK30
- Decision date
- Sep 18, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implantable, for incontinence.
- Applicant
- Medtronic Neuromodulation
- Product code
- EZW
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P970004. Subsequent supplements may change the device or its indications.
FDA decision timeline
P970004 · Original PMA
MEDTRONIC INTERSTIM THERAPY SYSTEM FOR URINARY CONTROL
P970004/S427 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S428 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S430 · Related supplement
InterStim Therapy System; Verify Evaluation System
P970004/S431 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S432 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S435 received
Application receipt date recorded by FDA.
P970004/S433 · Related supplement
InterStim Therapy System; Verify Evaluation System
P970004/S434 · Related supplement
InterStim Therapy System; Verify Evaluation System
P970004/S421 · Related supplement
InterStim Therapy System
P970004/S436 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S435 · FDA decision
30-Day Notice
P970004/S438 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S426 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S439 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S441 · Related supplement
InterStim Therapy System; Verify Evaluation System
P970004/S442 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S443 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S424 · Related supplement
InterStim TM Therapy System, Verify Evaluation System
P970004/S437 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S444 · Related supplement
SNS Urinary Neurostimulator Models 97800, 97810; SNS Urinary Screening Trialing Systems Model 3531
P970004/S440 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Urinary Programming Systems A510, A511, A520, A521)
P970004/S445 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S446 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Urinary Neurostimulator)
P970004/S447 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Urinary Implantable Neurostimulators 97800, 97810)
P970004/S449 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S448 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S450 · Related supplement
InterStim Therapy System; Verify Evaluation System (3550-05, 3560031, 3889, 978A1, 978B1)
P970004/S451 · Related supplement
InterStim Therapy System; Verify Evaluation System; InterStim SNS Urinary Lead Model 978B1
P970004/S452 · Related supplement
InterStim TM Therapy System; Verify TM Evaluation System (97800)
P970004/S453 · Related supplement
InterStim Therapy System
P970004/S454 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S455 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S456 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S458 · Related supplement
InterStim Therapy System Verify Evaluation System
P970004/S457 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S459 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S460 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Urinary Neurostimulator 97800), (SNS Urinary Neurostimulator I
Timeline entries are records held by MedtechLedger for P970004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P970004
Explore the linked device profile
Other records with product code EZW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Neuspera Sacral Neuromodulation (SNM) SystemP240031/S005 | Neuspera Medical, Inc. | PMA supplement | Aug 21, 2026 | FDA |
Axonics Sacral Neuromodulation SystemP180046/S113 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Aug 7, 2026 | FDA |
Axonics Sacral Neuromodulation SystemP180046/S110 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Jul 24, 2026 | FDA |
Axonics SNM SystemP180046/S112 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Jun 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Neuromodulation
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P970004/S435
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records







